New Releases from NCBI BookshelfUblituximab for treating relapsing multiple sclerosis.Ublituximab for treating relapsing multiple sclerosis.
Post Content
Uncategorized
New Releases from NCBI BookshelfAn Examination of the Return on Investment of Generic Injectable Prescription Drugs: Brief [Internet].An Examination of the Return on Investment of Generic Injectable Prescription Drugs: Brief [Internet].
The generic injectable drug market has recently experienced numerous shortages, which impose substantial public health costs. One potential cause of
Uncategorized
New Releases from NCBI BookshelfCharacteristics of Part D Drugs in Shortage: ASPE Report [Internet].Characteristics of Part D Drugs in Shortage: ASPE Report [Internet].
In this Report, we matched a sample of Part D drugs and biological products that had price changes between January
Uncategorized
New Releases from NCBI BookshelfLow- and No-Calorie Sweetened Beverages and Growth, Body Composition, and Risk of Obesity: A Systematic Review [Internet].Low- and No-Calorie Sweetened Beverages and Growth, Body Composition, and Risk of Obesity: A Systematic Review [Internet].
This systematic review was conducted by the 2025 Dietary Guidelines Advisory Committee as part of the process to develop the
Uncategorized
New Releases from NCBI BookshelfPembrolizumab with chemotherapy before surgery (neoadjuvant) then alone after surgery (adjuvant) for treating resectable non-small-cell lung cancer.Pembrolizumab with chemotherapy before surgery (neoadjuvant) then alone after surgery (adjuvant) for treating resectable non-small-cell lung cancer.
Post Content
